Oncology

for BIO 2024

Search text

Active Filters

Allotransplantation

2 results

(0.08 seconds)

Epigenetic therapy for prostate cancer treatment

CU23069

This technology combines anti-androgen therapy with epigenetic modification for the treatment or prevention of neuroendocrine prostate cancer.

11Allotransplantation Adenocarcinoma Antiandrogen

Jia Li Michael Shen Ph.D.

Joan Martinez

Medicine

Columbia University Medical Center (CUMC)Naomi Berrie Diabetes Center

2023-06-27

Recombinant ILT3 protein-produced antibodies for immunotherapy treatment of cancer

CU15207

This technology is a recombinant protein-induced antibody collection against Immunoglobulin-Like Transcript 3 (ILT3) that can modulate cancer cell growth and induce immune checkpoint blockade.

26Allotransplantation Acute myeloid leukemia Antibody

George Vlad Ph.D.Nicole Suciu-Foca Zheng Xu

Sara Gusik

Pathology

College of Physicians and Surgeons (CUMC)Columbia University Medical Center (CUMC)

2023-03-08